pci围手术期调脂治疗

pci围手术期调脂治疗

ID:34532608

大小:1.26 MB

页数:61页

时间:2019-03-07

pci围手术期调脂治疗_第1页
pci围手术期调脂治疗_第2页
pci围手术期调脂治疗_第3页
pci围手术期调脂治疗_第4页
pci围手术期调脂治疗_第5页
资源描述:

《pci围手术期调脂治疗》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、他汀类的作用TheBenefitofStatinTherapyBeforeandAfterCoronaryRevascularization首都医科大学附属北京安贞医院北京市心肺血管疾病研究所颜红兵Meta-AnalysisoftheRoleofStatinTherapyinReducingMIFollowingElectivePCI•Moodetal.selectedstudiesthatrandomizedptswhounderwentelectivePCItostatintherapyversusplacebo/usualcare.•Tobeincluded,statin

2、therapywasrequiredtobeinitiatedaroundthetimeofPCI,andindividualoutcomedatawererequiredtobecollected.•TheprimaryendpointwasMI.•Thesecondaryendpointswereall-causemortality,CVmortality,CABGorPCI,andstroke.Moodetal.AmJCardiol.2007Sep15;100(6):919-23StudiesIncludedinMeta-Analysis•6studiesweresele

3、cted:PREDICT-PreventionofRestenosisbyElisorAfterTransluminalCoronaryAngioplastyFLARE-FluvastatinAngioplastyRestenosisGAIN-GermanAtorvastatinIntravascularUltrasoundLIPS-LescolInterventionPreventionStudyARMYDA-AtorvastatinforReductionofMIDuringAngioplastyBriguorietal-Randomized3,941pts(1

4、,967tostatinsand1,974toplacebos)Moodetal.AmJCardiol.2007Sep15;100(6):919-23CholesterolDataofStudyParticipants(StatinArm/PlaceboArm)VariablePREDICTFLAREGAINLIPSARMYDABriguorietalBaselineTotalcholesterol228/231222/223228/242200/199--197/196(mg/dl)LDLcholesterol155/157153/153155/166131/132--121

5、/122(mg/dl)Follow-upTotalcholesterol195/239--156/215----168/193*(mg/dl)LDLcholesterol119/159102/14986/14095/147--93/121*(mg/dl)*LevelatindexprocedureLDL=low-densitylipoproteinMoodetal.AmJCardiol.2007Sep15;100(6):919-23OddsofMIafterPCIOddsRatio95%CIPREDICTFLAREGAINLIPSARMYDABriguoriOverallOR=

6、0.57(0.42-0.78)Moodetal.AmJCardiol.2007Sep15;100(6):919-23CumulativeCVMortalityResults•ThecumulativeincidenceofCVmortalityinptsamongthestatingroupvsplacebogroupwas0.71%vs1.2%,respectively(OR0.58,95%CI0.30to1.11,p=0.10).•Theweightedmeandurationoffollow-upwas20.6months,andtheabsolutedifference

7、betweenthegroupswas0.8%(p=0.10).Moodetal.AmJCardiol.2007Sep15;100(6):919-23CumulativeRepeatSurgicalorPCI•Amongtheptsrandomizedtostatintherapyversusplacebo,thecumulativeincidenceofrepeatCABGorPCIwas19.6%vs21.9%,respectively(OR0.89,95%CI0.78to1.02,p=

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。